Daniel Faga - Jan 3, 2025 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role: President, CEO, Director
Signature: /s/ Eric Loumeau, Attorney-in-Fact
Stock symbol: ANAB
Transactions as of: Jan 3, 2025
Transactions value $: -$288,003
Form type: 4
Date filed: 1/7/2025, 05:27 PM
Previous filing: Jul 24, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANAB	Common Stock	Options Exercise		+34.7K	+8.6%		438K	Jan 3, 2025	Direct	F1, F2
transaction	ANAB	Common Stock	Tax liability	-$190K	-13K	-2.98%	$14.60	425K	Jan 3, 2025	Direct	F3, F4
transaction	ANAB	Common Stock	Options Exercise		+17.9K	+4.2%		443K	Jan 6, 2025	Direct	F1
transaction	ANAB	Common Stock	Tax liability	-$97.7K	-6.39K	-1.44%	$15.30	436K	Jan 6, 2025	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANAB	Restricted Stock Unit	Options Exercise	$0	-34.7K	-25%	$0.00	104K	Jan 3, 2025	Common Stock	34.7K		Direct	F1, F5
transaction	ANAB	Restricted Stock Unit	Options Exercise	$0	-17.9K	-33.33%	$0.00	35.7K	Jan 6, 2025	Common Stock	17.9K		Direct	F1, F6
transaction	ANAB	Restricted Stock Unit	Award	$0	+107K		$0.00	107K	Jan 7, 2025	Common Stock	107K		Direct	F1, F7
transaction	ANAB	Stock Option (right to buy)	Award	$0	+306K		$0.00	306K	Jan 7, 2025	Common Stock	306K	$14.83	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2	Reflects the acquisition of 212 shares acquired under the Company's ESPP.
F3	Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.
F4	The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
F5	The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F6	The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F7	The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F8	The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.